Clinicopathologic efficacy of copper bromide plus/yellow laser (578 nm with 511 nm) for treatment of melasma in Asian patients

Dermatol Surg. 2010 Jun;36(6):885-93. doi: 10.1111/j.1524-4725.2010.01564.x. Epub 2010 May 7.

Abstract

Background: Melasma is a common pigmentary disorder in Asians. Although the pathogenesis of melasma is not yet fully understood, there are several hypotheses supporting angiogenetic factors related to some types of melasma.

Objective: To test the efficacy of copper bromide laser in the treatment of Korean women with melasma.

Materials and methods: Clinical parameters included physician and patient assessment and Melasma Area and Severity Index score. The intensity of pigmentation and erythema was measured using a chromometer. To evaluate histopathologic changes, punch biopsies from melasma were obtained from four patients. Immunohistochemical staining for Melan-A, endothelin 1, CD34, and vascular endothelial growth factor (VEGF) antigen of the melasma lesions was observed.

Results: Mean MASI score decreased dramatically after treatment. Patients exhibited telangiectatic erythema within the melasma lesion. The values of L(*) reflecting intensity of pigmentation increased, and the values of a(*) as the measurement of redness decreased after the treatments. Expression of Melan-A, CD34, endothelin-1, and VEGF decreased after treatment.

Conclusion: The potential application of an antiangiogenetic laser for the treatment of melasma specially accompanied by pronounced telangiectasia in Asian skin is a possible treatment option.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antigens, CD34 / metabolism
  • Asian People*
  • Cohort Studies
  • Female
  • Humans
  • Korea
  • Lasers, Gas / therapeutic use*
  • Low-Level Light Therapy / instrumentation*
  • Melanosis / ethnology
  • Melanosis / pathology*
  • Melanosis / radiotherapy*
  • Middle Aged
  • Severity of Illness Index
  • Treatment Outcome
  • Vascular Endothelial Growth Factor A / metabolism

Substances

  • Antigens, CD34
  • Vascular Endothelial Growth Factor A